Utama › Kanser (semua jenis) › Texas › Houston
Kajian klinikal Kanser (semua jenis) di Houston, TX
121 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- The University of Texas - MD Anderson Cancer Center, Houston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Mengambil pesertaKajian pemerhatian
- The University of Texas M.D. Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, Houston
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Mengambil pesertaFasa 3
- Investigative Site, Houston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Mengambil pesertaFasa 3
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of JNJ-1761981 in Participants With Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Mengambil pesertaFasa 2
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Houston Methodist Hospital, Houston
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Houston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Mengambil pesertaFasa 1/2
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- Houston Methodist Cancer Center, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 6, Houston
Intratumoral N17350 in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson, Houston
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Mengambil pesertaKajian pemerhatian
- UT MD Anderson Cancer Center, Houston
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- The University of Texas Health Science Center at Houston, Houston
- University of Texas- MD Anderson, Houston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Mengambil pesertaFasa 1/2
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
Statins to Prevent Cancer Associated Blood Clots
Mengambil pesertaFasa 4
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center, Houston
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Mengambil pesertaFasa 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, Houston
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Mengambil pesertaFasa 1
- Houston Methodist Hospital ( Site 0103), Houston
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Mengambil pesertaFasa 1/2
- The University of Texas Md Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Mengambil pesertaFasa 1/2
- NEXT Oncology ( Site 1011), Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Mengambil pesertaFasa 1
- Investigational Site Number: 401, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- UT MD Anderson, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Mengambil pesertaFasa 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Mengambil pesertaFasa 2
- Kelsey-Seybold Clinic, Houston
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
ORB-021 In Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- MDAC, Houston
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Mengambil pesertaFasa 3
- Houston Metro Urology, Houston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Mengambil pesertaFasa 3
- MD Anderson Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
Mengambil peserta
- MD Anderson, Houston
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
Mengambil pesertaKajian pemerhatian
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Mengambil pesertaFasa 1
- The University of Texas M. D. Anderson Cancer Center, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Mengambil pesertaFasa 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- Texas Childrens Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- Methodist Willowbrook Hospital, Houston
- dan 1 lagi
IDOV-Immune for Advanced Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
New Assessment System in Measuring Symptom Distress in Cancer Patients
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- M D Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Mengambil pesertaFasa 2
- MD Anderson Cancer Center, Houston
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- MD Anderson Cancer Center, Houston
Decoupling Immunotherapy Toxicity and Cancer Response
Mengambil pesertaKajian pemerhatian
- The University of Texas M. D. Anderson Cancer Center, Houston
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
Mengambil pesertaFasa 3
- M D Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Mengambil peserta
- M D Anderson Cancer Center, Houston
Long-Term Follow-Up of Recipient of Gene Transfer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Texas MD Anderson Cancer Center, Houston
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Oncology Consultants /ID# 268323, Houston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Genetics Studies of Cancer Patients and Their Relatives
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Multi Center Study of Sexual Toxicities After Radiotherapy
Mengambil pesertaKajian pemerhatian
- M.D. Anderson Cancer Center, Houston
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, Houston
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2/3
- The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Mengambil pesertaFasa 1
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
Active Living After Cancer: Implementation Within Be Well Acres Homes
Mengambil peserta
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- University of Texas MD Anderson Cancer Center, Houston
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- MDACC, Houston
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
Mengambil pesertaFasa 1/2
- M D Anderson Cancer Center, Houston
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
Mengambil pesertaFasa 2/3
- MD Anderson Cancer Centerr, Houston
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Mengambil pesertaFasa 2
- University of Texas MD Anderson Cancer Center, Houston
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
Mengambil pesertaKajian pemerhatian
- MD Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Grace Clinic, Houston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Mengambil pesertaFasa 2
- Retina Consultants of Texas, Bellaire · 7 mi jauh
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Mengambil pesertaFasa 2
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Mengambil pesertaKajian pemerhatian
- Md Anderson Cancer Center, Houston
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Mengambil pesertaFasa 2
- Baylor St. Luke's Medical Center, Houston
- Ben Taub Hospital (Harris Health Systems), Houston
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Mengambil peserta
- M D Anderson Cancer Center, Houston
Primary Tumor Research and Outcomes Network
Mengambil pesertaKajian pemerhatian
- The University of Texas M.D. Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Mengambil peserta
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of YL242 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- US-203, Houston
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Mengambil pesertaFasa 3
- Houston Methodist Neal Cancer Center, Houston
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Mengambil pesertaFasa 2
- MD Anderson Cancer Center, Houston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Mengambil pesertaKajian pemerhatian
- MD Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Childhood Cancer Predisposition Study (CCPS)
Mengambil pesertaKajian pemerhatian
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Houston
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Oncology Consultants, P.A., Houston
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
Mengambil peserta
- Baylor College of Medicine- McNair Campus, Houston
- Baylor College of Medicine, Houston
- Ben Taub General Hospital, Houston
- dan 1 lagi
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Mengambil pesertaFasa 2
- The University of Texas Health Science Center at Houston, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Mengambil pesertaFasa 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Trial of DFP-14927 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Mengambil pesertaFasa 1/2
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- The University of Texas MD Anderson Cancer Center, Houston
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Mengambil pesertaFasa 2
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
- Harris Health Smith Clinic, Houston
A Study in Patients With Advanced Cancers
Mengambil pesertaFasa 1/2
- University of Texas MD Anderson Cancer Center, Houston
Kajian Kanser (semua jenis) di bandar lain
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
- St. Louis, MO46 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher47 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.